Bank of New York Mellon’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6M | Sell |
287,552
-11,440
| -4% | -$735K | ﹤0.01% | 1589 |
|
|
2026
Q1 | $16.9M | Sell |
298,992
-6,223
| -2% | -$405K | ﹤0.01% | 1631 |
|
|
2025
Q4 | $24.5M | Sell |
305,215
-44,868
| -13% | -$3.01M | ﹤0.01% | 1420 |
|
|
2025
Q3 | $17.1M | Sell |
350,083
-26,225
| -7% | -$1.62M | ﹤0.01% | 1628 |
|
|
2025
Q2 | $28.1M | Buy |
376,308
+6,256
| +2% | +$414K | 0.01% | 1336 |
|
|
2025
Q1 | $23.5M | Sell |
370,052
-16,437
| -4% | -$1.12M | ﹤0.01% | 1409 |
|
|
2024
Q4 | $30.2M | Sell |
386,489
-15,785
| -4% | -$1.27M | 0.01% | 1323 |
|
|
2024
Q3 | $32.3M | Sell |
402,274
-83,856
| -17% | -$6.77M | 0.01% | 1292 |
|
|
2024
Q2 | $40.2M | Sell |
486,130
-1,096
| -0.2% | -$96.4K | 0.01% | 1169 |
|
|
2024
Q1 | $41.6M | Sell |
487,226
-29,418
| -6% | -$2.31M | 0.01% | 1146 |
|
|
2023
Q4 | $44.2M | Sell |
516,644
-10,786
| -2% | -$932K | 0.01% | 1121 |
|
|
2023
Q3 | $47.2M | Sell |
527,430
-7,197
| -1% | -$643K | 0.01% | 1018 |
|
|
2023
Q2 | $45.5M | Sell |
534,627
-12,177
| -2% | -$1.03M | 0.01% | 1068 |
|
|
2023
Q1 | $45.2M | Sell |
546,804
-13,412
| -2% | -$1.09M | 0.01% | 1069 |
|
|
2022
Q4 | $44.1M | Sell |
560,216
-54,019
| -9% | -$4.34M | 0.01% | 1072 |
|
|
2022
Q3 | $45.5M | Buy |
614,235
+17,929
| +3% | +$1.29M | 0.01% | 1018 |
|
|
2022
Q2 | $38.9M | Sell |
596,306
-15,910
| -3% | -$942K | 0.01% | 1140 |
|
|
2022
Q1 | $38.7M | Buy |
612,216
+26,233
| +4% | +$1.43M | 0.01% | 1272 |
|
|
2021
Q4 | $31.1M | Buy |
585,983
+6,168
| +1% | +$376K | 0.01% | 1461 |
|
|
2021
Q3 | $40.9M | Buy |
579,815
+23,237
| +4% | +$1.47M | 0.01% | 1269 |
|
|
2021
Q2 | $37.1M | Buy |
556,578
+65,794
| +13% | +$4.66M | 0.01% | 1362 |
|
|
2021
Q1 | $54.5M | Sell |
490,784
-5,647
| -1% | -$699K | 0.01% | 1054 |
|
|
2020
Q4 | $59M | Sell |
496,431
-3,059
| -0.6% | -$329K | 0.01% | 949 |
|
|
2020
Q3 | $43.6M | Sell |
499,490
-44,231
| -8% | -$3.87M | 0.01% | 998 |
|
|
2020
Q2 | $48.7M | Sell |
543,721
-47,736
| -8% | -$4.82M | 0.01% | 893 |
|
|
2020
Q1 | $58.9M | Buy |
591,457
+20,910
| +4% | +$2.27M | 0.02% | 689 |
|
|
2019
Q4 | $65.6M | Sell |
570,547
-20,440
| -3% | -$2.47M | 0.02% | 824 |
|
|
2019
Q3 | $74.5M | Sell |
590,987
-48,374
| -8% | -$6.14M | 0.02% | 732 |
|
|
2019
Q2 | $76.9M | Sell |
639,361
-116,516
| -15% | -$11.5M | 0.02% | 722 |
|
|
2019
Q1 | $66.1M | Sell |
755,877
-66,669
| -8% | -$6.06M | 0.02% | 790 |
|
|
2018
Q4 | $82.3M | Sell |
822,546
-32,229
| -4% | -$3.39M | 0.03% | 615 |
|
|
2018
Q3 | $97.9M | Buy |
854,775
+69,094
| +9% | +$7.15M | 0.03% | 628 |
|
|
2018
Q2 | $70.5M | Buy |
785,681
+122,168
| +18% | +$10.3M | 0.02% | 781 |
|
|
2018
Q1 | $48.5M | Sell |
663,513
-1,451
| -0.2% | -$99.6K | 0.01% | 1023 |
|
|
2017
Q4 | $38.6M | Sell |
664,964
-17,462
| -3% | -$919K | 0.01% | 1150 |
|
|
2017
Q3 | $30.6M | Sell |
682,426
-39,213
| -5% | -$1.63M | 0.01% | 1299 |
|
|
2017
Q2 | $28.5M | Sell |
721,639
-34,951
| -5% | -$1.44M | 0.01% | 1328 |
|
|
2017
Q1 | $30.7M | Buy |
756,590
+35,852
| +5% | +$1.4M | 0.01% | 1283 |
|
|
2016
Q4 | $29M | Buy |
720,738
+48,769
| +7% | +$1.84M | 0.01% | 1294 |
|
|
2016
Q3 | $24.3M | Buy |
671,969
+32,820
| +5% | +$1.13M | 0.01% | 1329 |
|
|
2016
Q2 | $18.5M | Sell |
639,149
-22,635
| -3% | -$684K | 0.01% | 1446 |
|
|
2016
Q1 | $23.1M | Buy |
661,784
+14,181
| +2% | +$458K | 0.01% | 1314 |
|
|
2015
Q4 | $20.9M | Sell |
647,603
-2,621
| -0.4% | -$85K | 0.01% | 1370 |
|
|
2015
Q3 | $21M | Buy |
650,224
+119,690
| +23% | +$4.5M | 0.01% | 1382 |
|
|
2015
Q2 | $21.9M | Buy |
530,534
+5,342
| +1% | +$225K | 0.01% | 1420 |
|
|
2015
Q1 | $23.6M | Buy |
525,192
+6,485
| +1% | +$271K | 0.01% | 1375 |
|
|
2014
Q4 | $19.4M | Buy |
518,707
+3,710
| +0.7% | +$136K | 0.01% | 1488 |
|
|
2014
Q3 | $18M | Sell |
514,997
-5,417
| -1% | -$193K | ﹤0.01% | 1501 |
|
|
2014
Q2 | $18.4M | Sell |
520,414
-9,428
| -2% | -$315K | ﹤0.01% | 1532 |
|
|
2014
Q1 | $17.3M | Sell |
529,842
-255,076
| -32% | -$9.75M | ﹤0.01% | 1572 |
|
|
2013
Q4 | $33.1M | Buy |
784,918
+4,606
| +0.6% | +$190K | 0.01% | 1136 |
|
|
2013
Q3 | $31.1M | Sell |
780,312
-9,885
| -1% | -$415K | 0.01% | 1135 |
|
|
2013
Q2 | $32.7M | Buy |
+790,197
| New | +$32M | 0.01% | 1063 |
|
Other funds holding HAE
RRAM
FWIA
BTW
Bank of New York Mellon's HAE Position: Q2 2026 in Review
Bank of New York Mellon reduced its Haemonetics (HAE) stake by 3.8% in Q2 2026, selling an estimated $735K and leaving 287,552 shares worth $21.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1589.
Bank of New York Mellon first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $97.9M in Q3 2018. 181 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Bank of New York Mellon held 287,552 shares of Haemonetics worth $21.6M as of Q2 2026.
- Bank of New York Mellon sold 11,440 Haemonetics shares in Q2 2026, an estimated $735K.
- Haemonetics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1589 holding.
- Bank of New York Mellon first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Haemonetics position peaked at $97.9M in Q3 2018.
- 181 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.